Grace Therapeutics
GRCE
#10319
Rank
HK$0.29 B
Marketcap
HK$18.43
Share price
-0.84%
Change (1 day)
-29.93%
Change (1 year)

Revenue for Grace Therapeutics (GRCE)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Grace Therapeutics from 2010 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A
2024 N/A
2023 N/A
2022 N/A-100%
2021 HK$0.89 M42.81%
2020 HK$0.62 M
2019 N/A
2018 N/A
2015 HK$0.91 M-47.55%
2014 HK$1.75 M-24.2%
2013 HK$2.31 M-57.3%
2012 HK$5.41 M
2010 N/A